Neurosteer

Remote Brain Activity Monitoring and Assessment Platform

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in August 2015 by Prof. Nathan Intrator, Neurosteer operates with 11–50 employees. The company has secured $2.56M in total capital across two funding rounds. In September 2015, Neurosteer received seed funding from Arkady Volozh.

Business overview

Neurosteer develops a solution for the early detection and treatment of neurological disorders. Its core technology integrates a medical-grade wearable device with a cloud-based system to provide real-time brain activity monitoring and assessment. The company focuses on delivering objective biomarkers for the early onset of conditions such as Parkinson's disease, Alzheimer's disease, dementia, and epilepsy, serving the health tech and life sciences sectors.

Strategic signal

In March 2020, Neurosteer unveiled a wearable device aimed at detecting Alzheimer's disease. This development signals the company's commitment to addressing significant neurological challenges through innovative, non-invasive diagnostic tools, potentially expanding its market reach and clinical impact in the digital healthcare and medical devices sectors.

Company Intelligence Q&A

When was Neurosteer founded?
Neurosteer was founded in August 2015 by Prof. Nathan Intrator.
What is Neurosteer's primary focus?
Neurosteer focuses on developing a platform for early detection and more effective treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, dementia, and epilepsy, using real-time brain activity monitoring.
What type of funding has Neurosteer received?
Neurosteer has raised a total of $2.56M across two funding rounds. In September 2015, the company secured seed funding from Arkady Volozh.
What is Neurosteer's core technology?
Neurosteer's core technology involves a medical-grade wearable device and a cloud-based system that processes sensor data using advanced algorithms to analyze a single EEG channel into over 100 individual components for real-time brain activity assessment.
Has Neurosteer received any grants?
In June 2018, Neurosteer received a grant from EU Horizon 2020.